8-K/A: Polomar Health Services Completes Acquisition of Polomar Specialty Pharmacy, LLC

Polomar Health Services, Inc. finalized its acquisition of Polomar Specialty Pharmacy, LLC on September 30, 2024, making it a wholly-owned subsidiary.

Summary

• Polomar Health Services, Inc., formerly known as Trustfeed Corp., completed the acquisition of Polomar Specialty Pharmacy, LLC on September 30, 2024.
• The acquisition involved Polomar becoming a wholly-owned subsidiary of Polomar Health Services, Inc.
• Polomar Health Services issued shares of its common stock in exchange for 100% of Polomar's membership interests.
• The company filed an amendment to its original 8-K report to include historical financial statements and pro forma financial information.
• Polomar's audited financial statements for the period from April 26, 2023 (inception) through December 31, 2023, and unaudited statements for the three and six months ended June 30, 2024, are included in the report.
• Pro forma combined balance sheets as of June 30, 2024, and statements of operations for the six months ended June 30, 2024, and the year ended December 31, 2023, are also provided.

Sentiment

Score: 3

Explanation: The document reveals significant financial challenges, including substantial losses, a going concern warning, and reliance on related-party debt. While the acquisition is a strategic move, the underlying financial health of the acquired entity is concerning, leading to a negative sentiment.

Positives

• The acquisition of Polomar Specialty Pharmacy, LLC expands Polomar Health Services' business operations.
• The pro forma financial statements provide a clear picture of the combined entity's financial position.
• The inclusion of audited and unaudited financial statements provides transparency.

Negatives

• Polomar Specialty Pharmacy LLC has a history of net losses, with a net loss of $171,497 for the period from April 26, 2023 to December 31, 2023, and a net loss of $262,070 for the six months ended June 30, 2024.
• Polomar Specialty Pharmacy LLC has a significant accumulated deficit of $433,567 as of June 30, 2024.
• The auditor's report for Polomar Specialty Pharmacy LLC raises substantial doubt about the company's ability to continue as a going concern.
• The company has significant related party debt of $454,288 as of June 30, 2024.

Risks

• Polomar Specialty Pharmacy LLC's ability to continue as a going concern is uncertain due to insufficient cash and working capital.
• The company is dependent on future capital injections and revenue growth to sustain operations.
• There is no assurance that sufficient financing will be available on favorable terms.
• The company has a history of losses and a significant accumulated deficit.
• The company has significant related party debt.

Future Outlook

The company's future success depends on growing sales, securing capital injections, and achieving synergies with the holding company's other subsidiaries. Management is seeking additional equity financing but there is no assurance that sufficient financing will be available on favorable terms.

Management Comments

• Management plans to obtain resources through revenue growth, expense reductions, and potential offerings of equity securities or debt.
• Management acknowledges that current plans do not alleviate substantial doubt about the company's ability to continue as a going concern.

Industry Context

The acquisition of Polomar Specialty Pharmacy, LLC is a strategic move for Polomar Health Services, Inc. to expand its presence in the specialty pharmacy sector. The company is operating in a competitive market and will need to execute its business plan effectively to achieve profitability.

Comparison to Industry Standards

• The financial performance of Polomar Specialty Pharmacy LLC, particularly its net losses and going concern issues, is concerning when compared to established players in the specialty pharmacy industry.
• Companies like CVS Health and Walgreens Boots Alliance, which have established specialty pharmacy divisions, typically demonstrate more robust financial performance and stability.
• The pro forma combined financials show a significant accumulated deficit, which is not typical for established companies in the healthcare sector.
• The reliance on related-party debt is also a deviation from industry norms, where companies typically have access to more diverse funding sources.

Related Party Transactions

• The company has significant related-party debt with Daniel Gordon, totaling $454,288 as of June 30, 2024.
• The company entered into a promissory note and loan agreement with Reprise Management, Inc., a related party, for up to $700,000 on August 13, 2024.

Stakeholder Impact

• Shareholders face increased risk due to the company's financial instability and going concern issues.
• Employees may be concerned about job security due to the company's financial challenges.
• Customers may be impacted if the company's financial issues affect its ability to provide services.
• Suppliers and creditors face increased risk due to the company's financial instability.

Next Steps

• The company needs to focus on growing sales and reducing expenses to improve its financial position.
• Management needs to secure additional financing to address the going concern issue.
• The company needs to integrate Polomar Specialty Pharmacy, LLC into its operations effectively.

Key Dates

Keywords

acquisition, pharmacy, financial statements, pro forma, merger, healthcare, Polomar Health Services, Polomar Specialty Pharmacy, going concern, related party debt